Dianthus Therapeutics | Capitaux D'Emprunt



Loan Capital Changement Date
Adcock Ingram Holdings ZAR 220.08M 18M 2024-12
Alaunos Therapeutics USD 0 0 2024-12
Avita Medical AUD 42.24M 1.25M 2024-12
Celltrion KRW 114.04B 8.35B 2025-03
Cspc Pharmaceutical CNY 56.14M 10.18M 2024-12
Dianthus Therapeutics USD 0 0 2024-12
Divis Laboratories Ltd 20M 0 2025-03
IQVIA Holdings USD 14.18B 1.07B 2025-06
Kangmei Pharma CNY 84.24M 3.67M 2025-06
Knight Therapeutics CAD 36.51M 2.04M 2024-09
Laboratorios Farma EUR 101.36M 20.86M 2025-06
Malin Corporation EUR 0 0 2024-12
Medical Developments International AUD 1.76M 150K 2024-12
Moderna USD 32M 3M 2025-06
Neuren Pharmaceuticals AUD 0 0 2024-12
Organigram Holdings CAD 52.8M 9.51M 2025-06
Organon & Co USD 8.9B 36M 2025-06
Pharma Mar EUR 37.57M 2.66M 2025-06
Qiagen NV USD 884.85M 467.8M 2025-06
Revvity USD 3.21B 45.94M 2025-06
Sartorius EUR 4.09B 112.3M 2025-06
Sino Biopharmaceutical CNY 2.08B 915.48M 2024-12
Tectonic Therapeutic USD 186K 201K 2025-06
Tilray USD 316.63M 15.02M 2024-11
Viatris USD 12.79B 1.39B 2025-06
Xeris Pharmaceuticals USD 218.63M 1.62M 2025-06
Zz Pientze Pharmaceu 196.31M 8.23M 2025-06


Dianthus Therapeutics Capitaux D'Emprunt - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Sep 2025.